Tag #Epidermolysis Bullosa

Showing 1 to 2 of 2 results

english.elpais.com
🌐 85% Global Worthiness
News related image

Losartan Shows Promise for Butterfly Skin, but Funding for Clinical Trial Remains a Challenge

Losartan, a hypertension drug, shows promise in treating epidermolysis bullosa (butterfly skin) lesions, but a €5-10 million clinical trial is needed for EMA approval, highlighting challenges in repurposing drugs for rare diseases.

Progress

36% Bias Score

Good Health and Well-being
forbes.com
🌐 95% Global Worthiness
News related image

FDA Approves First Gene Therapy for RDEB, Showcasing Innovative Funding Model

The FDA approved ZEVASKYN, the first autologous cell-based gene therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB), a significant advancement driven by EB Research Partnership's innovative venture philanthropy model, offering hope to 500,000 people globally.

Progress

52% Bias Score

Good Health and Well-being

Showing 1 to 2 of 2 results